The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by el-Mallakh, R. S.
* Articles by Kleinman, J. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by el-Mallakh, R. S.
* Articles by Kleinman, J. E.

J Neuropsychiatry Clin Neurosci 1991; 3:383-386
Copyright © 1991 by American Neuropsychiatric Association


REGULAR ARTICLES

The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia

RS el-Mallakh, DG Kirch, R Shelton, KJ Fan, G Pezeshkpour, S Kanhouwa, RJ Wyatt and JE Kleinman
Neuropsychiatry Branch, National Institute of Mental Health, Rockville, Maryland 20857.

The large, hyperchromic, cholinergic neurons of the nucleus basalis of Meynert (nbM) and the presence of senile plaques were quantified in postmortem brain tissue from 10 intellectually impaired schizophrenic patients, seven intellectually intact schizophrenic patients, seven control subjects, and three patients with Alzheimer's disease. The two groups of schizophrenic patients did not show any significant differences when compared with the control group in nbM cell density or in plaque frequency. The Alzheimer's disease patients showed the expected decrease in nbM neuronal density and increase in plaques compared with the controls. The data suggest that compromised cognitive function in schizophrenia is not associated with diffuse neuropathology of the basal forebrain cholinergic system.


This article has been cited by other articles:


Home page
Schizophr BullHome page
J. A. Gray and B. L. Roth
Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia
Schizophr Bull, September 1, 2007; 33(5): 1100 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
A. J. Dwork, E. S. Susser, J. Keilp, C. Waniek, D. Liu, M. Kaufman, Z. Zemishlany, and I. Prohovnik
Senile Degeneration and Cognitive Impairment in Chronic Schizophrenia
Am J Psychiatry, November 1, 1998; 155(11): 1536 - 1543.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1991 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org